Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF).
Clinical trial NCT04215796 · UNKNOWN
Trial details
- NCT number
- NCT04215796
- Sponsor
- Dosentrx Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2022-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.